UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in shares of Concentrix Corporation (NASDAQ:CNXC – Free Report) by 20.7% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 100,381 shares of the company’s stock after selling 26,155 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Concentrix were worth $2,249,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Osaic Holdings Inc. lifted its holdings in Concentrix by 13.4% in the second quarter. Osaic Holdings Inc. now owns 2,222 shares of the company’s stock worth $118,000 after acquiring an additional 263 shares during the last quarter. State of Wyoming grew its holdings in shares of Concentrix by 6.2% during the fourth quarter. State of Wyoming now owns 5,029 shares of the company’s stock valued at $209,000 after purchasing an additional 293 shares during the last quarter. Deutsche Bank AG grew its holdings in shares of Concentrix by 4.7% during the fourth quarter. Deutsche Bank AG now owns 6,767 shares of the company’s stock valued at $281,000 after purchasing an additional 303 shares during the last quarter. Brevan Howard Capital Management LP raised its position in shares of Concentrix by 4.5% during the 2nd quarter. Brevan Howard Capital Management LP now owns 8,951 shares of the company’s stock worth $473,000 after purchasing an additional 384 shares during the period. Finally, California State Teachers Retirement System raised its position in shares of Concentrix by 1.1% during the 2nd quarter. California State Teachers Retirement System now owns 36,387 shares of the company’s stock worth $1,923,000 after purchasing an additional 384 shares during the period. Institutional investors and hedge funds own 90.34% of the company’s stock.
Analyst Ratings Changes
A number of research firms recently issued reports on CNXC. Canaccord Genuity Group reduced their price objective on Concentrix from $55.00 to $45.00 and set a “buy” rating for the company in a research report on Tuesday, June 30th. Zacks Research raised Concentrix from a “strong sell” rating to a “hold” rating in a research report on Monday, August 31st. Bank of America cut their target price on Concentrix from $32.00 to $26.00 and set a “neutral” rating on the stock in a research note on Tuesday, June 30th. Barrington Research reduced their price target on shares of Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a report on Tuesday, June 30th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Concentrix in a research report on Friday, July 24th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $32.75.
Concentrix Stock Performance
CNXC opened at $28.24 on Friday. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 1.46. The business’s 50 day moving average is $25.88 and its 200-day moving average is $26.93. The stock has a market cap of $1.72 billion, a PE ratio of -1.32, a price-to-earnings-growth ratio of 0.50 and a beta of 0.47. Concentrix Corporation has a twelve month low of $19.12 and a twelve month high of $57.88.
Concentrix (NASDAQ:CNXC – Get Free Report) last issued its quarterly earnings data on Monday, June 29th. The company reported $2.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). Concentrix had a positive return on equity of 19.82% and a negative net margin of 13.16%.The business had revenue of $2.46 billion during the quarter, compared to the consensus estimate of $2.47 billion. During the same period last year, the company earned $2.70 earnings per share. The business’s quarterly revenue was up 1.9% compared to the same quarter last year. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. On average, analysts predict that Concentrix Corporation will post 9.67 earnings per share for the current year.
Concentrix Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, August 4th. Investors of record on Friday, July 24th were paid a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 5.1%. The ex-dividend date was Friday, July 24th. Concentrix’s payout ratio is currently -6.75%.
Concentrix Profile
Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Further Reading
- Five stocks we like better than Concentrix
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Want to see what other hedge funds are holding CNXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Corporation (NASDAQ:CNXC – Free Report).
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.
